Intervacc’s Exclusive Distribution Agreement With Dechra Pharmaceuticals

Federica Tiefenthaler
Tagged:

Cirio advised Intervacc on the deal. Intervacc AB has entered into an exclusive distribution agreement with Dechra Pharmaceuticals PLC to commercialize Intervacc’s leading vaccine candidate Strangvac® in…

This content is for Standard 1 Year members only.
Login Join Now
Federica Tiefenthaler

Author: Federica Tiefenthaler

…

This content is for Standard 1 Year members only.
Login Join Now